Blueshift Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
+3,695
| New | +$258K | 0.08% | 322 |
|
|
2025
Q1 | – | Sell |
-4,355
| Closed | -$285K | – | 399 |
|
|
2024
Q4 | $285K | Buy |
4,355
+912
| +26% | +$59.8K | 0.1% | 264 |
|
|
2024
Q3 | $268K | Buy |
+3,443
| New | +$268K | 0.07% | 296 |
|
|
2024
Q1 | – | Sell |
-3,999
| Closed | -$269K | – | 276 |
|
|
2023
Q4 | $269K | Buy |
+3,999
| New | +$269K | 0.14% | 199 |
|
|
2023
Q3 | – | Sell |
-4,892
| Closed | -$350K | – | 284 |
|
|
2023
Q2 | $350K | Buy |
+4,892
| New | +$350K | 0.13% | 189 |
|
|
2022
Q3 | – | Sell |
-5,947
| Closed | -$393K | – | 601 |
|
|
2022
Q2 | $393K | Buy |
+5,947
| New | +$393K | 0.06% | 377 |
|
|
2022
Q1 | – | Sell |
-8,040
| Closed | -$468K | – | 829 |
|
|
2021
Q4 | $468K | Sell |
8,040
-12,234
| -60% | -$712K | 0.04% | 496 |
|
|
2021
Q3 | $1.22M | Buy |
20,274
+11,939
| +143% | +$717K | 0.07% | 358 |
|
|
2021
Q2 | $499K | Buy |
+8,335
| New | +$499K | 0.03% | 564 |
|
|
2020
Q1 | – | Sell |
-14,895
| Closed | -$743K | – | 214 |
|
|
2019
Q4 | $743K | Buy |
+14,895
| New | +$743K | 0.08% | 340 |
|
|
2019
Q1 | – | Sell |
-17,837
| Closed | -$677K | – | 703 |
|
|
2018
Q4 | $677K | Buy |
+17,837
| New | +$677K | 0.13% | 269 |
|